← Browse by Condition

Medical Condition

asthma

Total Trials

31

Recruiting Now

31

Trial Phases

Phase 2, Phase 4, Phase 3

Mepolizumab and Physical Activity in Severe Asthma

University Hospital, Lille

NCT07301736 Phase 2

Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma

Chiesi Farmaceutici S.p.A.

A 24-week rPMS Study in Real-world Setting for Enerzair

Novartis Pharmaceuticals

NCT05222529 Phase 2

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With Asthma

Bulgaria, Colombia, ...

Novartis Pharmaceuticals

Taiwan Severe Asthma Biologic Registry

Taichung Veterans General Hosp...

NCT07219173 Phase 2

A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma

United States, Argen...

Eli Lilly and Company

Automated Inhaler Monitoring for Asthma Medication Usage

Boston Children's Hospital

GRANITE: Airsupra Effectiveness in the Real World

The Extended Salford Lung Study ("Ex-SLS") Data Access Project

GlaxoSmithKline

Patient Reported Outcomes for Acute Asthma Care Treatment

Stanford University

Evaluation of Cardiopulmonary Parameters in Individuals With Asthma

Turkey (Türkiye)

Hacettepe University

NCT04743791 Phase 4

Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma

Sally E. Wenzel MD

Adult Arm of DZL All Age Asthma Cohort (ALLIANCE)

LungenClinic Grosshansdorf

NCT07011524 Phase 2

Study of CM512 Injection in Subjects With Moderate-to-severe Asthma

Keymed Biosciences Co.Ltd

LIving BEtteR With asThma - Intervention Development Study

University Hospital Southampto...

Effects of Salbutamol in Athletes and Implications for Screening and Sports

University of British Columbia

A Cohort for Inflammatory Respiratory Diseases: From Phenotyping to Personalised Medicine

NCT05757102 Phase 3

A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

United States, Argen...

GlaxoSmithKline

NCT06429475 Phase 3

Anti-Inflammatory Reliever South Africa

University of KwaZulu

Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave

Universitätsklinikum Hamburg-E...

A Comparison of Diagnostic Testing Modalities in the Assessment of Asthma

Portsmouth Hospitals NHS Trust

NCT04380038 Phase 4

Viral Infection in Asthma (VIA) Study

University of Virginia

Role of "Asthma School" in Disease Management

Istituti Clinici Scientifici M...

NCT06664619 Phase 3

A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

United States, Argen...

Teva Branded Pharmaceutical Pr...

Nutrition for Asthmatics

Pennington Biomedical Research...

NCT06433921 Phase 1

A Study to Compare the Relative Potency of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152a to HFA-134a in Mild Asthmatics Aged 18 to 65 Inclusive

GlaxoSmithKline

Molecular Allergen Component Resolved Diagnosis to Decide Immunotherapy

Universidade do Porto

Study of Inflammatory and Physiological Profiles of Healthy and Diseased Lung

Guy's and St Thomas' NHS Found...

Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

Gelb, Arthur F., M.D.

Study of the Effect of Innate on the Inflammatory Response to Endotoxin

National Institute of Environm...

Sarcopenia in Chronic Lung Diseases

Taichung Veterans General Hosp...